Valuation DexCom, Inc.

Stocks

Market Closed - Nasdaq 00:00:00 11/09/2026 +04			5-day change	1st Jan Change
84.51 ^USD	+0.75%		-5.78%	+27.33%

09-11	DexCom, Inc. Announces Appointment of Glenn S. Boehnlein as Director, Member of Operations & Innovation Committee and Audit Committee, Effective September 10, 2026	CI
09-09	DexCom, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 08:00 AM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	52,042	43,740	47,945	30,377	25,885	31,891	-	-
Change	-	-15.95%	9.61%	-36.64%	-14.79%	23.2%	-	-
Enterprise Value (EV) ¹	52,692	45,068	49,813	31,073	26,209	31,130	30,829	30,014
Change	-	-14.47%	10.53%	-37.62%	-15.65%	18.78%	-0.96%	-2.64%
P/E	346x	138x	95.5x	54.8x	31.8x	33.9x	28.5x	23.5x
PBR	23.1x	20.5x	23.1x	15.1x	9.3x	11.2x	9.35x	7.2x
PEG	-	1x	1.6x	5.94x	0.7x	1.8x	1.5x	1.1x
Capitalization / Revenue	21.3x	15x	13.2x	7.53x	5.55x	6.1x	5.5x	4.94x
EV / Revenue	21.5x	15.5x	13.8x	7.7x	5.62x	5.95x	5.32x	4.65x
EV / EBITDA	111x	60x	49.1x	28.1x	19.4x	18.7x	16x	13.5x
EV / EBIT	142x	92.9x	69.3x	41x	27x	25x	21.3x	17.4x
EV / FCF	989x	148x	97.3x	49.3x	24.3x	30.5x	25.3x	20.4x
FCF Yield	0.1%	0.68%	1.03%	2.03%	4.11%	3.28%	3.96%	4.9%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.3875	0.82	1.3	1.42	2.09	2.495	2.969	3.596
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	2,448	2,910	3,622	4,033	4,662	5,230	5,800	6,461
EBITDA ¹	472.7	751.6	1,014	1,105	1,349	1,666	1,921	2,218
EBIT ¹	370.7	485.1	718.6	757.1	969.3	1,247	1,447	1,722
Net income ¹	154.7	341.2	541.5	576.2	836.3	974.4	1,149	1,409
Net Debt ¹	650.1	1,328	1,868	695.9	323.2	-761.1	-1,061	-1,877
Reference price ²	134.24	113.24	124.09	77.77	66.37	84.51	84.51	84.51
Nbr of stocks (in thousands)	387,688	386,258	386,374	390,595	390,016	377,361	-	-
Announcement Date	10/02/22	09/02/23	08/02/24	13/02/25	12/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
DEXCOM, INC.	33.62x	5.91x	18.54x	-.--%	31.65B
ABBOTT LABORATORIES	30.19x	4.1x	15.74x	2.44%	182B
MEDTRONIC PLC	19.44x	3.55x	12.69x	3.09%	118B
CENCORA, INC.	17.7x	0.21x	12.92x	0.74%	61.7B
HOYA CORPORATION	28.46x	7x	18.03x	1.4%	50.55B
BECTON, DICKINSON AND COMPANY	34.65x	3.36x	11.52x	2.18%	48.98B
MEDLINE INC.	43.96x	1.28x	11.86x	0.21%	29.87B
WEST PHARMACEUTICAL SERVICES, INC.	39.29x	6.88x	24.67x	0.27%	23.71B
TERUMO CORPORATION	16.9x	2.69x	9.55x	1.64%	21.78B
SARTORIUS STEDIM BIOTECH	48.61x	6.57x	21.13x	0.44%	21.55B
Average	31.28x	4.16x	15.67x	1.24%	58.94B
Weighted average by Cap.	28.39x	3.87x	14.96x	1.85%